Your browser doesn't support javascript.
loading
Neurotensin receptor 1 facilitates intracellular and transepithelial delivery of macromolecules.
Bird, Joanna L; Simpson, Rachael; Vllasaliu, Driton; Goddard, Alan D.
Afiliação
  • Bird JL; School of Life Sciences, University of Lincoln, Lincoln LN6 7DL, UK.
  • Simpson R; School of Life Sciences, University of Lincoln, Lincoln LN6 7DL, UK.
  • Vllasaliu D; School of Pharmacy, University of Lincoln, Lincoln LN6 7DL, UK.
  • Goddard AD; School of Life Sciences, University of Lincoln, Lincoln LN6 7DL, UK. Electronic address: a.goddard@aston.ac.uk.
Eur J Pharm Biopharm ; 119: 300-309, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28690201
ABSTRACT
G protein-coupled receptors are expressed on the surface of eukaryotic cells and internalise in response to ligand binding. The actions of the hormone and neurotransmitter neurotensin (NT) are predominantly mediated by specific interactions with one such receptor, neurotensin receptor 1 (NTS1), which is upregulated in a variety of cancers, including pancreatic and breast tumours. NTS1 could therefore serve as a target for selective delivery of therapeutics. This study characterised the expression of NTS1 in HEK293 cells, as well as both polarised and non-polarised intestinal epithelial Caco-2 cells. NT-conjugated fluorophores were internalised in NTS1-expressing HEK293 and Caco-2 cells in a receptor-mediated fashion. Confocal microscopy revealed fluorophore localisation in the perinuclear region. Cell uptake and transport across the Caco-2 intestinal model of two NT-conjugated fluorophores (GFP and fluorescein) were compared to evaluate the effect of cargo size on cellular uptake. This work demonstrates that NT ligand conjugation is able to deliver relatively large macromolecular cargoes selectively into cells overexpressing NTS1 and the system is able to effectively translocate macromolecules across an intestinal epithelial model. NTS1 therefore shows potential as a drug delivery target not only for targeted but also non-invasive (oral) delivery of biotherapeutics for cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Neurotensina / Substâncias Macromoleculares Limite: Humans Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Neurotensina / Substâncias Macromoleculares Limite: Humans Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2017 Tipo de documento: Article